Who owns Benitec Biopharma Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BNTC from SEC Form 13F filings across 91 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 91 institutions disclosed 33.6M shares of Benitec Biopharma Inc. worth $334.6M — about 68% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
91
13F holders
$334.6M
value, 2026 filers
68%
of shares outstanding (33.6M sh)
16
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BNTC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 11.5M | $115.5M | 2.7% | 23.3% | 0.0% |
| 2 | FRANKLIN TEMPLETON INC | 2.4M | $22.4M | 0.0% | 4.9% | 0.0% |
| 3 | Janus Henderson Group Ltd.NEW | 2.3M | $23.4M | 0.0% | 4.7% | new |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.1M | $21.2M | 0.0% | 4.3% | 0.0% |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 1.9M | $18.5M | 0.2% | 3.7% | 0.0% |
| 6 | Nantahala Capital Management, LLC | 1.7M | $16.8M | 0.5% | 3.4% | +12.7% |
| 7 | BlackRock, Inc. | 1.4M | $14.3M | 0.0% | 2.9% | +1.5% |
| 8 | INFINITUM ASSET MANAGEMENT, LLC | 1.3M | $12.6M | 1.1% | 2.5% | +36.5% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $10.4M | 0.0% | 2.1% | +8.5% |
| 10 | Simplify Asset Management Inc. | 1.0M | $10.0M | 0.2% | 2% | -0.3% |
| 11 | MILLENNIUM MANAGEMENT LLC | 760,251 | $7.6M | 0.0% | 1.5% | -17.5% |
| 12 | Alyeska Investment Group, L.P. | 750,000 | $7.5M | 0.0% | 1.5% | 0.0% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 666,132 | $6.7M | 0.0% | 1.3% | +8.9% |
| 14 | Balyasny Asset Management L.P. | 649,954 | $6.5M | 0.0% | 1.3% | -0.1% |
| 15 | SILVERARC CAPITAL MANAGEMENT, LLC | 443,109 | $4.4M | 0.5% | 0.9% | -34.8% |
| 16 | STATE STREET CORP | 427,515 | $4.3M | 0.0% | 0.9% | +13.1% |
| 17 | AMERIPRISE FINANCIAL INC | 392,991 | $3.9M | 0.0% | 0.8% | -2.1% |
| 18 | CITADEL ADVISORS LLC | 271,278 | $2.7M | 0.0% | 0.5% | +233.0% |
| 19 | MYDA Advisors LLC | 260,000 | $2.6M | 0.3% | 0.5% | +4.0% |
| 20 | Schonfeld Strategic Advisors LLC | 235,525 | $2.4M | 0.0% | 0.5% | +0.1% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 198,678 | $2.0M | 0.0% | 0.4% | +23.4% |
| 22 | GOLDMAN SACHS GROUP INC | 193,550 | $1.9M | 0.0% | 0.4% | +8.7% |
| 23 | NORTHERN TRUST CORP | 191,849 | $1.9M | 0.0% | 0.4% | +7.5% |
| 24 | AWM Investment Company, Inc. | 187,977 | $1.9M | 0.2% | 0.4% | 0.0% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 146,389 | $1.5M | 0.0% | 0.3% | +2.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.